India Coronavirus Vaccine Market Analysis By Industry Size, Share, Opportunity and Forecast, 2027

FY2017 – FY2027

INDIA CORONAVIRUS VACCINE MARKET FORECAST & OPPORTUNITIES

www.techsciresearch.com MARKET INTELLIGENCE . CONSULTING

Scope of Report

Product of Interest (POI): Coronavirus Vaccine

A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS ‑CoV ‑2), the virus that causes coronavirus disease 2019 (COVID‑19). The COVID ‑19 vaccines are widely celebrated for their role in reducing the spread, severity, and death caused by COVID-19.

Market Segmentation

REGION

TYPE

Year Range

•

mRNA Based

• South

•

Non-Replicating Viral Vector Based

• West

Review Period

•

Inactivated Vaccine

• East

FY2017 – FY2020

• North

Base Year

FY2021 END USER •

Hospitals

•

Clinics

•

Research Institutes

•

Others

Estimated Year

FY2022 Forecast Period

FY2023 – FY2027

2

Table of Contents S. No.

Contents

1.

Product Overview (A brief description of the category and product inclusions considered under the scope of the study to give clear picture to the client about the product of interest.)

2.

Research Methodology (A detailed methodology on how we have derived the market related information and what are the measures that has been taken to validate the data.)

3.

Impact of COVID-19 on India Coronavirus Vaccine Market

4.

Executive Summary (This chapter covers summary of the complete study.)

5.

Voice of Customer/Customer Insights

6.

India Coronavirus Vaccine Market Outlook, FY2017-FY2027 (This chapter includes a brief overview of the product of interest market such as total market’s growth rate, expected growth rate, key growth levers, leading region, top grossing product types, etc. It includes more of a qualitative information about the market.)

6.1.

Market Size & Forecast (This chapter would include the market size i.e., the revenue generated from the India Coronavirus Vaccine market in one year. In this case, the market size will be provided in Value terms for historic period (FY2017-FY2020); current/base year (FY2021); estimated year (FY2022E); and forecast (FY2023-FY2027) 6.1.1.

6.2.

By Value & Volume

Market Share & Forecast (The overall product of interest bifurcated/split among various segments. ) 6.2.1.

By Type (mRNA Based, Non-Replicating Viral Vector Based, Inactivated Vaccine)

6.2.2.

By End User (Hospitals, Clinics, Research Institutes, Others)

6.2.3.

By Region 6.2.3.1.

6.2.4.

6.3.

© TechSci Research

By State (Top 10 States)

By Company (FY 2021)

Product Market Map

3

Table of Contents S No.

Contents

7.

India mRNA Based Coronavirus Vaccine Market Outlook 7.1.

Market Size & Forecast 7.1.1.

7.2.

By End User

India Non- Replicating Viral Vector Based Coronavirus Vaccine Market Outlook 8.1.

Market Size & Forecast 8.1.1.

8.2.

By Value & Volume

Market Share & Forecast 8.2.1.

9.

By Value & Volume

Market Share & Forecast 7.2.1.

8.

Page No.

By End User

India Inactivated Coronavirus Vaccine Market Outlook 9.1.

Market Size & Forecast 9.1.1.

9.2.

By Value & Volume

Market Share & Forecast 9.2.1.

By End User

4 4

Table of Contents S. No. 10.

Contents Market Dynamics 10.1.

Drivers

10.2.

Challenges

11.

Market Trends & Development

12.

Policy & Regulatory Landscape

13.

Comparative Analysis of Approved Vaccines in the India

14.

Vaccination Scenario in the India

15.

Analysis of Prospective Vaccines (Vaccines in Clinical Trials)

16.

Import-Export Analysis

17.

Pricing Analysis

18.

India Economic Profile

19.

Competitive Landscape

© TechSci Research

19.1.

Competitive Landscape

19.2.

Company Profiles (Top 10 Companies) 19.2.1.

Company Details

19.2.2.

Products & Services

19.2.3.

Financials (As Reported)

19.2.4.

Key Market Focus & Geographical Presence

19.2.5.

Recent Developments

19.2.6.

Key Management Personnel

5

Table of Contents S. No.

Contents

20.

Strategic Recommendations (Based on the findings of the report strategic recommendations on how to enter and expand market share)

21.

About Us & Disclaimer

© TechSci Research

6

RESEARCH METHODOLOGY

Research Methodology

Market Profiling

In-depth secondary research was conducted to determine top players in India coronavirus vaccine market, overall market size and segmental market size.

Formulating Questionnaire

In order to conduct industry experts’ interviews, TechSci formulated a detailed discussion guide.

Developing List of Respondents

List of industry players and industry specialists was developed.

Data Collection

TechSci conducted interviews with industry experts and industry players for data collection and verification.

Primary Research

Data Collection

Data Filter Research & & Analysis Intelligence

Actionable Insights

Business Solution

Primary Research Research Primary LinkedIn  LinkedIn TechSci Internal Internal  TechSci Database Database

© TechSci Research

 Identifying Key Opinion Leaders  Questionnaire Design  In-depth Interviews

Secondary Secondary Research Research CompanyWebsites Websites  Company CompanyAnnual Annual  Company Reports Reports White Paper Paper Study Study  White Financial Reports Reports  Financial Investor  Investor Presentations Presentations Regulatory Body Body  Regulatory Associations, etc. etc.  Associations,

Data Validation

Data obtained as a result of primary and secondary research was validated through rigorous triangulation.

Desk Research  Recent Developments  Market Changing Aspects/Dynamics  Government Policies  Conclusion

Data Analysis

The data was scrutinized using MS-Excel, statistical tools and internal proprietary database to obtain qualitative and quantitative insights about India coronavirus vaccine market.

Company Analysis  Market Participants  Key Strengths

Paid Sources Sources Paid Factiva  Factiva Hoovers  Hoovers

8

Research Methodology Baseline Methodology

Our dedicated team of industry experts has monitored and analyzed various aspects of India coronavirus vaccine market. The team has analyzed the outlook of various segments of this market, while considering the major influencing factors such as increasing use of coronavirus vaccine. The study includes market forecasting, which would enable our clients to take better decisions while planning their strategy to achieve sustainability in India coronavirus vaccine market.

Methodology Followed for Calculation of Market Size:

• Market Size by Value & Volume: Market size, in terms of value & volume, for the year FY2021 was calculated based on information collected through exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as coronavirus vaccine manufacturers, distributors, supplier companies, end users, industry experts and other industry participants.

• The team interviewed more than 10-20 coronavirus vaccine manufacturers, 50 – 75 major end users, 15 – 20 industry experts and other stakeholders in India coronavirus vaccine market to obtain the overall market size from FY2017 to FY2021, which was validated by the Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data during FY2017-FY2021. © TechSci Research

9

Research Methodology •

Respondents were asked about the current and future market growth rates, market shares by type, by end user, by company and by each region. Removing the outlier responses, the geometric mean of growth estimates and supplier wise revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various segments were further triangulated from other stakeholders depending upon the segments of coronavirus vaccine.

Methodology Followed for Calculation of Market Shares: •

Market shares by type, by end user, by company and by each region were calculated based on the responses received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various types of coronavirus vaccine. The final shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers.

Methodology Followed for Forecasting: •

TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.

•

Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast India coronavirus vaccine market , TechSci Research used various forecast techniques such as: 

Moving Average



Time Series Analysis



Regression Analysis



Econometric and Judgmental Analysis

© TechSci Research

10

Research Methodology TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during short, medium and long term period to estimate the demand emanating in the market. It should be noted that the figures compiled are only for the organized market including market share data.

Partial List of Companies Interviewed

Key Secondary Sources

 Serum Institute of India (SII)

 World Bank

 Biological E. Limited

 TechSci Research Proprietary Database & Knowledge

 Cipla Ltd (Moderna’s Vaccine)

Repository

 Bharat Biotech International Limited

 Company Annual Reports

 Astra Zeneca Pharma India Limited

 Industry Magazines

 Panacea Biotec Ltd.

 Industry Reports

 Hetero Biopharma Ltd.

 News Dailies

 Virchow Biotech Private Limited

 Credible Paid Databases

 Gland Pharma Limited  Stelis Biopharma Pvt. Ltd.

© TechSci Research

11

Industry Brief Need for protection against the Coronaviridae virus and its strains is driving the growth of India coronavirus vaccine market, in the forecast period, FY2017-FY2027.

According to TechSci report on, “India Coronavirus vaccine Market By Infection Type (SARS-CoV, MERS-CoV, SARS-CoV-2) By Vaccine Type (Virus vaccine, Viral vector vaccine, Nucleic acid vaccines, Protein based vaccine, Others) By Product Type (Monovalent Vaccine v/s Multivariant Vaccine) By Route of Administration (Oral, Intramuscular, Intranasal) By Patient Type (Pediatric v/s Adult) By End User (Hospitals, Clinics, Research Institutes, Others) By Region, Competition Forecast & Opportunities, FY2027”, India coronavirus vaccine market has shown promising growth in historical years until FY2020 and is expected to continue its growth in upcoming forecast years from FY2022 to FY2027. Governmental aids to enhance the research and development of the prevention drugs and finding the solution to the fastest growing pandemic is driving the growth of the India coronavirus vaccine market. Key players are actively involved in enhancing the quality of the drugs as well as the easier distribution of the vaccine all over the country.

The private investments are also boosting the growth of the India coronavirus vaccine market in the upcoming five years. Moreover, inorganics developments like collaborations among the players, agreements with the distributors for the effective supply of the drugs to the end users, are major growth factors behind the impressive CAGR of India coronavirus vaccine market.

Wuhan City, China was the firstly discovered geography where the COVID-19 virus outbreak was addressed. Within next 3 months, world health organization (WHO) confirmed the outbreak to be a pandemic and death threat to the human population. This catastrophic pandemic has already claimed millions of lives and although the precaution measures are widely accepted, the number of cases has not yet died. With the spur of variant strains of the virus, a new wave of infection is still suspected. This would support the market growth since the death threat is concerning. Also, increasing healthcare expenditures is going to support the market growth, actively.

India coronavirus vaccine Market is segmented by infection type, vaccine type, product type, route of administration, patient type, end user, regional distribution, and competitional landscape. Based on infection type the market is categorized into SARS-CoV, MERS-CoV, and SARS-CoV-2. Infections caused by SARS-CoV-2 is considered most lethal and easily transmitted, thus can be reasoned for maximum market share because it is causing pandemic all over the world including India at a rapid pace. The transmission is as simple as basic contact, droplet, airborne, fomite, faecal-oral, bloodborne, mother-to-child, and animal-to-human transmission. SARS-CoV is a less lethal but a similar strain of the coronavirus, whereas MERS-CoV is specific to Middle East countries and is contagious and sometimes fatal.

Based on product type, the market is categorized into monovalent vaccine, and multivariant vaccine. Monovalent vaccines are specific antigen targeting vaccines. Whereas multivariant vaccines target multiple antigens or here, multiple strains of the same virus making it preferable. Even in the current year 2021, country still faces the threat from the evolving strains of the virus causing concerns toward the threatening pandemic that may reinstate the complete lockdown situation. Based on these facts, multivariant vaccines are anticipated to dominate the market in the forecast period.

Based on route of administrations the market is further segmented into oral, intramuscular, and intranasal. Intramuscular administration through injecting the vaccines in two stages is prevalent in the country. Therefore, intramuscular route of administration is anticipated to dominate the future market. Oral administrations may have the largest share owing to the availability of the vaccine for infants and children. Intramuscular and intranasal administration is often painful and may cause physical irritation effects whereas oral vaccines are completely painless and has ease of administration.

Some of the top players in the India coronavirus vaccine market are, Serum Institute of India Pvt. Ltd., Bharat Biotech International Ltd., Zydus Cadila Ltd., Pfizer India Ltd., Panacea Biotec Ltd., Indian Immunologicals Ltd., Mynvax Pvt. Ltd., Biological E Ltd., Hetero Biopharma Ltd., Dr Reddy’s Laboratories Ltd., among others. The companies are involving themselves into research and development for the methods of better quality, and various quality analysis tests to provide the better products.

“India coronavirus vaccination system is following a systematic approach to administer the vaccines to all the population. Elderly, children and patient population was administered early looking at the chances of infection to be more in them. By the end of FY2021, system allowed all the population to complete their vaccination process.

Although the number of cases has decreased significantly, the country is also struggling with new strain spread. general awareness and concerns among the population will increase vaccination process. Moreover, west India is a promising region for the market looking at the still increasing cases of corona patients in states like Maharashtra,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

12

Sample Data - Snapshot

10.00 FY2017

30.00

20.00

40.00

CAGR BY VALUE: XX% CAGR BY VOLUME: XX %

50.00

60.00

FY2021

FY2022E

By Value (USD Million)

70.00

90.00

80.00

15.00

14.00

13.00

12.00

11.00

10.00

9.00

8.00

7.00

6.00

5.00

India Coronavirus Vaccine Market Size, By Value (USD Million) & By Volume (Units), FY2017-FY2027F

110.00

100.00

CAGR BY VALUE: XX%

FY2027F

CAGR BY VOLUME: XX %

By Volume (Units)

India Coronavirus Vaccine Market Share, By Type, By Value, FY2017-FY2027F mRNA Based FY2027F FY2026F FY2025F FY2024F FY2023F FY2022E FY2021 FY2020 FY2019 FY2018 FY2017

Non-Replicating Viral Vector Based

33% 33% 33% 33% 33% 33% 33% 33% 33% 33% 33%

33% 33% 33% 33% 33% 33% 33% 33% 33% 33% 33%

Inactivated Vaccine

34% 34% 34% 34% 34% 34% 34% 34% 34% 34% 34%

India mRNA Based Coronavirus Vaccine Market Share, By End User, By Value, FY2017-FY2027F Hospitals FY2027F FY2026F FY2025F FY2024F FY2023F FY2022E FY2021 FY2020 FY2019 FY2018 FY2017

25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%

Clinics

25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%

Research Institutes

25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%

Others

25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%

13

Report Ordering

Report Name: INDIA CORONAVIRUS VACCINE MARKET FORECAST & OPPORTUNITIES FY2017 – FY2027 License Type

Price

Single User License

$3500

Multi-User License

$4500

Custom Research License

$7500

To View Sample OR Purchase Report

14

About Us & Disclaimer

TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.

Related Reports •

United States Hospital Market By Ownership (Public v/s Private) By Type (General, Specialty, Multi- Specialty) By Type of Services (In-Patient Services v/s Out-Patient Services) By Bed Capacity (Up to 100 beds, 100-500 beds, Above 500 beds) By Region, Competition Forecast & Opportunities, 2026

•

India Insulin Delivery Devices Market By Product Type (Pens, Pumps, Pen Needles, Others) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others) By End User (Hospitals & Clinics, Homecare, Others) By Region, Competition Forecast & Opportunities, FY2027 TechSci Research – North America 708 Third Avenue, Manhattan, New York, United States Tel: +1- 646- 360- 1656 Email: sales@techsciresearch.com www.techsciresearch.com

TechSci Research – Europe 54, Old brook, Bretton, Peterborough, United Kingdom Email: sales@techsciresearch.com www.techsciresearch.com

TechSci Research – Asia-Pacific B – 44, Sector – 57, Noida, National Capital Region, U.P. - India Tel: +91-120-4523900 Email: sales@techsciresearch.com www.techsciresearch.com

Disclaimer The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.